to
September 5, 2023 blogger analysis, analytics, Business, cannabis, CBD, compliance, consumer, CQC, CQCExpo, Cultivation, David Vaillencourt, dispensary, extraction, Federal, government, Growing, industry, International, lab, laboratories, laboratory, Law, Legal, legalization, Legalize, legislation, license, marijuana, market, Medical, Medicial Marijuana, Medicine, product, quality, Recreational, regulation, Regulations, regulatory, Retail, safety, sale, seed, Soapbox, state, Stop Smoking Marijuana, Stop Smoking Pot, test, Testing, THC, The GMP Collective, to, weed, withdrawal, workshop
Recently, Congress requested detailed information regarding the regulation of CBD and other cannabinoids. This comes on the heels of frustration around federal inaction with regards to cannabinoid-containing products produced from Cannabis sativa L. plant extracts that can be classified as “hemp” products amidst the clear need for safety standards that goes above and beyond state […]
analysis, analytics, Business, cannabis, CBD, compliance, consumer, CQC, CQCExpo, Cultivation, David Vaillencourt, dispensary, extraction, Federal, government, Growing, industry, International, lab, laboratories, laboratory, Law, legal, legalization, Legalize, legislation, license, marijuana, market, Medical, Medicine, product, quality, Recreational, regulation, Regulations, regulatory, Retail, safety, sale, seed, Soapbox, state, test, Testing, THC, The GMP Collective, to, workshop
July 25, 2023 blogger analysis, analytics, Business, Business Analysis, cannabis, compliance, Conference, consumer, contaminants, CQC, CQCExpo, Cultivation, Darwin Millard, David Vaillencourt, dispensary, Edibles & Processing, extraction, Federal, heavy metals, Kathy Knutson, label, labeling, legalization, Legalize, legislation, license, marijuana, market, Medicial Marijuana, microbial, New Jersey, October, Operations, Parsippany, potency, product, Product Development, quality, RC - Cannabis & Hemp Testing Solutions, RC - Cannabis Analysis, regulation, Regulations, regulatory, Retail, safety, sale, seed, state, Stop Smoking Marijuana, Stop Smoking Pot, test, Testing, THC, to, weed, withdrawal, workshop
As the legal landscape surrounding cannabis continues to evolve, the creation of robust, sensible and consistent safety regulations remains stalled. A patchwork of broadly inconsistent state rules and regulations, along with years of federal inaction and policy stagnation have the potential to create significant risks for consumers. Given the industry’s explosive, multi-billion-dollar growth, consumers have access […]
analysis, analytics, Business, Business Analysis, cannabis, compliance, Conference, consumer, contaminants, CQC, CQCExpo, Cultivation, Darwin Millard, David Vaillencourt, dispensary, Edibles & Processing, extraction, Federal, heavy metals, Kathy Knutson, label, labeling, legalization, Legalize, legislation, license, marijuana, market, microbial, New Jersey, October, Operations, Parsippany, potency, product, Product Development, quality, RC - Cannabis & Hemp Testing Solutions, RC - Cannabis Analysis, regulation, Regulations, regulatory, Retail, safety, sale, seed, state, test, Testing, THC, to, workshop
December 9, 2022 blogger Affinity, analysis, analytics, bio, Business, Business Analysis, cannabinoid, cannabis, Christina Diarcangelo, clinical, diabetic, drug, Federal, government, Growing, head, industry, lab, laboratories, laboratory, labs, Law, Legal, legalization, Legalize, legislation, license, marijuana, Medical, Medicial Marijuana, Medicine, nerve, pain, Partners, pharma, pharmaceutical, product, Product Development, quality, regulation, regulatory, safety, state, Stop Smoking Marijuana, Stop Smoking Pot, Studies, Study, test, Testing, therapeutics, to, trial, weed, withdrawal, Zelira
Affinity Bio Partners on Working with Zelira Therapeutics to Complete Enrolment for Diabetic Nerve Pain Drug Trial It’s an exciting time in the medical cannabis community as Zelira, a global leader in the research, development and commercialization of clinically validated cannabinoid medicines, and Affinity Bio Partners, a leading, global clinical research organization, have completed enrollment […]
Affinity, analysis, analytics, bio, Business, Business Analysis, cannabinoid, cannabis, Christina Diarcangelo, clinical, diabetic, drug, Federal, government, Growing, head, industry, lab, laboratories, laboratory, labs, Law, legal, legalization, Legalize, legislation, license, marijuana, Medical, Medicine, nerve, pain, Partners, pharma, pharmaceutical, product, Product Development, quality, regulation, regulatory, safety, state, Studies, Study, test, Testing, therapeutics, to, trial, Zelira